Early Refractive And Visual Outcomes After Smile Pro Surgery For Correcting Myopic Astigmatism With The Visumax 800

To evaluate outcomes of SMILE PRO surgery using the VISUMAX 800 for correcting myopic astigmatism.

Hong Son Eye Hospital, Ha Noi, Viet Nam.

Retrospective study in 756 eyes of 364 patients with myopic astigmatism treated with SMILE PRO surgery at Hong Son Eye Hospital, Viet Nam from June to October in 2023. Patients with sphere up to – 10.00 D, astigmatism up to – 5.00 D, age between 18 and 40 years old, a preoperative corrected distance visual acuity (CDVA) of 20/25 or better. Follow up at 1 week, 1 month, 3 months . Outcomes were analyzed with SPSS 20.0 and vector analysis was performed by the Alpins method.

The preoperative mean spherical equivalent refraction (SEQ) was – 5.92 ± 2.26 D (range: - 1.00 to - 12.50 D) and reduced significantly at 1 month (- 0.04 ± 0.46 D; P < 0.05) and remained stable until 3 months. The SEQ was maintained within ± 0.50 D in 84.3 % and ± 1.00 D in 98.1 % of eyes. The uncorrected distance visual acuity was 20/25 or better in 92.9 % of eyes at 3 months. The postoperative astigmatism was under 0.50 D in 78.3% of eyes and under 1.00 D in 98% of eyes. One line of CDVA was lost in 0.13 % of eyes and no eyes lost two or more lines. One eye had suction loss during the operation, no other complications.

SMILE PRO surgery with the VISUMAX 800 is a safe and effective treatment for myopic astigmatism patients.